News archive 2010

11 March 2010
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer

10 March 2010
AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

8 March 2010
mtm laboratories Announces the European Launch of CINtec(R) PLUS

8 March 2010
BG Medicine and Abbott to Develop Galectin-3 Test for the i-STAT® System

19 February 2010
ABLYNX Receives EUR 1.2 Million Grant to Further Advance its Anti-IL-6R Programme, ALX-0061

16 February 2010
MTM LABORATORIES - CINtec® p16 Histology test increases accuracy in diagnosing high grade cervical lesions

11 February 2010
ABLYNX Win Patent Opposition Case

11 February 2010
ABLYNX Selects GPCR Targeting Development Candidate and Announces New Data on Alternative Routes of Delivery

9 February 2010
FlowCardia, Inc. Initiates CENTRAL Study Enrollment

29 January 2010
BG MEDICINE files Registration Statement for proposed Initial Public Offering at NASDAQ

28 January 2010
BG Medicine Announces Receipt Of CE Mark For Its Galectin-3 Blood Test

28 January 2010
Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

27 January 2010
BG Medicine Announces Receipt of CE Mark for its Galectin-3 Blood Test and Initiates Commercialization in the European Union

11 January 2010
Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti-EGFR Sym004

11 January 2010
AMT submits its lead product Glybera® Application for Marketing Authorisation Application to EMA

6 January 2010
Amsterdam Molecular Therapeutics receives € 4 million Innovation Credit for Duchenne Muscular Dystrophy programme

4 January 2010
Pieris Appoints a New CEO

Bottles with golden caps